Results of surgical treatment of aortic stenosis in patients with a narrow aortic root after Ozaki surgery and bioprosthetics: A retrospective single-center study
- 作者: Bazylev V.V.1, Mikulyak A.I.1, Khadiev D.M.1, Karnakhin V.A.1, Belik A.O.1
-
隶属关系:
- Federal Center for Cardiovascular Surgery
- 期: 卷 15, 编号 3 (2024)
- 页面: 191-200
- 栏目: Original study articles
- URL: https://ogarev-online.ru/2221-7185/article/view/281609
- DOI: https://doi.org/10.17816/CS628564
- ID: 281609
如何引用文章
全文:
详细
BACKGROUND: Aortic stenosis (AS) itself is a common disease in patients of older populations, and its combination with a narrow aortic root puts the surgeon in front of choosing the most optimal option. The advantages of Ozaki's operation include hemodynamics close to the native aortic valve (AV) and the absence of the need for lifelong anticoagulant therapy.
AIM: To evaluate the hospital and long-term results of surgical treatment of patients with AS and a narrow fibrous ring who underwent Ozaki surgery or AV prosthetics with a biological prosthesis.
MATERIALS AND METHODS: In total, 836 isolated Ozaki operations or combined interventions of this kind were performed at the Federal Center for Cardiovascular Surgery (Penza). This retrospective single-center study included 150 patients with critical AC (effective opening area ≤1 cm2) in whose surgical treatment tactics Ozaki surgery or prosthetics with a biological prosthesis were used.
RESULTS: In the early postoperative period, group 1 patients had significantly lower values of the average and maximum gradients on the aortic valve and a larger area of the effective opening of the aortic valve. Also, in group 1 patients, the postoperative period of stay in intensive care is significantly higher, which is a consequence of the longer duration of the operation, the time of artificial circulation and myocardial ischemia. Long-term mortality is higher in the group with prosthetics of AV (Log Rank=0.006). Freedom from re-operation according to the analysis, there was no significant difference between the groups (Log Rank=0.226).
CONCLUSION: Ozaki surgery demonstrates the best hemodynamic characteristics on AV in comparison with a biological prosthesis in patients with a narrow fibrous ring of AV in the early and long-term follow-up periods.
作者简介
Vladlen Bazylev
Federal Center for Cardiovascular Surgery
Email: cardio-penza@yandex.ru
ORCID iD: 0000-0001-6089-9722
SPIN 代码: 3153-8026
MD, Dr. Sci. (Medicine), professor
俄罗斯联邦, 6 Stasova str., 440071 PenzaArtur Mikulyak
Federal Center for Cardiovascular Surgery
Email: mikulyak.artur@gmail.com
ORCID iD: 0000-0002-9519-5036
SPIN 代码: 3303-2522
MD, Cand. Sci. (Medicine)
俄罗斯联邦, 6 Stasova str., 440071 PenzaDzhokhar Khadiev
Federal Center for Cardiovascular Surgery
编辑信件的主要联系方式.
Email: dagdjomusa1995@mail.ru
ORCID iD: 0000-0003-3762-6472
MD
俄罗斯联邦, 6 Stasova str., 440071 PenzaVadim Karnakhin
Federal Center for Cardiovascular Surgery
Email: vkhin@mail.ru
ORCID iD: 0000-0002-1815-7116
SPIN 代码: 5680-7893
MD, Cand. Sci. (Medicine)
俄罗斯联邦, 6 Stasova str., 440071 PenzaArtur Belik
Federal Center for Cardiovascular Surgery
Email: belik.artur@list.ru
ORCID iD: 0000-0003-0407-5504
MD
俄罗斯联邦, 6 Stasova str., 440071 Penza参考
- Otto CM, Nishimura RA, Bonow RO, et al. 2020 ACC/AHA Guideline for the management of patients with valvular heart disease: A report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2021;143(5):e72–e227. doi: 10.1161/CIR.0000000000000923
- Bazylev VV, Kobzev EE, Babukov RM, Rosseykin EV. Ozaki operation for narrow fibrous ring of aortic valve — a new solution to an old problem? Thoracic and cardiovascular surgery. 2018;60(3):217–225. doi: 10.24022/0236-2791-2018-60-3-217-225
- Ozaki S, Kawase I, Yamashita H, et al. Aortic valve reconstruction using self-developed aortic valve plasty system in aortic valve disease. Interact Cardiovasc Thorac Surg. 2011;12(4):550–3. doi: 10.1510/icvts.2010.253682
- Rosseykin EV, Bazylev VV, Batrakov PA, Karnakhin VA, Rastorguev AA. Immediate results of aortic valve cusp replacement with autopericardium using the Ozaki technique. Blood circulation pathology and cardiac surgery. 2016;20(2):44–48. doi: 10.21688-1681-3472-2016-2-44-48
- Flameng W, Herregods MC, Vercalsteren M, et al. Prosthesis-patient mismatch predicts structural valve degeneration in bioprosthetic heart valves. Circulation. 2010;121(19):2123–2129. doi: 10.1161/CIRCULATIONAHA.109.901272
- Cribier A, Eltchaninoff H, Bash A, et al. Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description. Circulation. 2002;106(24):3006–3008. doi: 10.1161/01.CIR.0000047200.36165.B8
- Fishbein GA, Schoen FJ, Fishbein MC. Transcatheter aortic valve implantation: status and challenges. Cardiovasc Pathol. 2013;23(2):65–70. doi: 10.1016/j.carpath.2013.10.001
- Mylotte D, Andalib A, Thériault-Lauzier P, et al. Transcatheter heart valve failure: a systematic review. Eur Heart J. 2015;36(21):1306–1327. doi: 10.1093/eurheartj/ehu388
- Makkar RR, Fontana G, Jilaihawi H, et al. Possible subclinical leaflet thrombosis in bioprosthetic aortic valves. N Engl J Med. 2015;373(21):2015–2024. doi: 10.1056/NEJMoa1509233
- Okutucu S, Niazi AK, Oliveira D, et al. A systematic review on durability and structural valve deterioration in TAVR and surgical AVR. Acta Cardiol. 2021;76(9):921–932. doi: 10.1080/00015385.2020.1858250
- Schoen FJ, Levy RJ. Calcification of tissue heart valve substitutes: progress toward understanding and prevention. Ann Thorac Surg. 2005;79(3):1072–1080. doi: 10.1016/j.athoracsur.2004.06.033
- Alvarez-Cabo R. Sparing aortic valve techniques. J Thorac Dis. 2017;9(Suppl. 6):S526–S532. doi: 10.21037/jtd.2017.03.94
- Aicher D, Fries R, Rodionycheva S, et al. Aortic valve repair leads to a low incidence of valve-related complications. Eur J Cardiothorac Surg. 201;3(1):127–132. doi: 10.1016/j.ejcts.2009.06.021
- Hammermeister K, Sethi GK, Henderson WG, et al. Outcomes 15 years after valve replacement with a mechanical versus a bioprosthetic valve: final report of the Veterans Affairs randomized trial. J Am Coll Cardiol. 200;3(4):1152–1158. doi: 10.1016/s0735-1097(00)00834-2
补充文件
